In this issue:
Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates
An ethical framework for global vaccine allocation
The public’s role in COVID-19 vaccination
Will a SARS-CoV-2 vaccine match all currently circulating variants?
Durability of response after SARSCoV-2 mRNA-1273 vaccination
Antibody levels after routine infant vaccinations in preterm infants
Two-year follow-up of the ‘No jab, no pay’ vaccination policy in Australia
Pertussis and influenza immunisation coverage of pregnant women in NZ
Impact of routine quadrivalent meningococcal conjugate vaccination in the US
Indirect benefits of PCV10 in children in Finland
Please login below to download this issue (PDF)